These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7046537)

  • 21. Sialic acid uptake is necessary for virulence of Pasteurella multocida in turkeys.
    Tatum FM; Tabatabai LB; Briggs RE
    Microb Pathog; 2009 Jun; 46(6):337-44. PubMed ID: 19366625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of turkey poults to Pasteurella multocida and a comparison with older turkeys.
    Bond RE; Olson LD
    Avian Dis; 1974; 18(4):619-22. PubMed ID: 4433306
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of complement sensitivity with virulence of Pasteurella multocida isolated from turkeys.
    Snipes KP; Hirsh DC
    Avian Dis; 1986; 30(3):500-4. PubMed ID: 3767810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of plasmid acquisition on potential virulence attributes of Pasteurella multocida.
    Lee MD; Wooley RE
    Avian Dis; 1995; 39(3):451-7. PubMed ID: 8561727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial purification of cross-protection factor(s) from Pasteurella multocida.
    Rimler RB
    Avian Dis; 1994; 38(4):778-89. PubMed ID: 7702511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of live avirulent PM-1 and CU fowl cholera vaccines in turkeys.
    Hopkins BA; Olson LD
    Avian Dis; 1997; 41(2):317-25. PubMed ID: 9201394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capsular hyaluronic acid-mediated adhesion of Pasteurella multocida to turkey air sac macrophages.
    Pruimboom IM; Rimler RB; Ackermann MR; Brogden KA
    Avian Dis; 1996; 40(4):887-93. PubMed ID: 8980821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgA, IgG, and anti-Pasteurella multocida antibody levels in bursectomized and/or cyclophosphamide-treated turkeys after CU vaccination.
    Schlink GT; Olson LD; Saif YM; Jackwood DJ
    Avian Dis; 1993; 37(3):668-72. PubMed ID: 8257356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the use of a long-acting oxytetracycline in turkeys: efficacy against experimental infections with Alcaligenes faecalis and Pasteurella multocida.
    Skeeles JK; Swafford WS; Wages DP; Hellwig HM; Slavik MF; Beasley JN; Houghten GE; Blore PJ; Crawford D
    Avian Dis; 1983; 27(4):1126-30. PubMed ID: 6651700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fate of Pasteurella multocida in the blood vascular system of turkeys following intravenous inoculation: comparison of an encapsulated, virulent strain with its avirulent, acapsular variant.
    Snipes KP; Ghazikhanian GY; Hirsh DC
    Avian Dis; 1987; 31(2):254-9. PubMed ID: 3619818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization of turkey breeder hens against fowl cholera by combined oral and wing-web administration of attenuated (CU) pasteurella multocida.
    Ghazikhanian GY; Dungan WM; Kelly BJ
    Avian Dis; 1983; 27(1):133-40. PubMed ID: 6847537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotype results of Pasteurella multocida isolated from poultry in South Carolina.
    Derieux WT
    Avian Dis; 1974; 18(2):265-6. PubMed ID: 4828583
    [No Abstract]   [Full Text] [Related]  

  • 33. Fowl cholera immunization in turkeys. I. Efficacy of various cell fractions of Pasteurella multocida as vaccines.
    Brown J; Dawe DL; Davis RB; Foster JW; Srivastava KK
    Appl Microbiol; 1970 May; 19(5):837-41. PubMed ID: 5422310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble fractions of Pasteurella multocida: their protective qualities against fowl cholera in turkeys.
    Kodama H; Matsumoto M; Fuquay JI; Syuto B
    Avian Dis; 1983; 27(1):283-91. PubMed ID: 6847544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of pathogenicity to the growth of Pasteurella multocida serotype 3,4 isolates in normal turkey plasma.
    Lee MD; Brown J; Wooley RE; Glisson JR
    Avian Dis; 1988; 32(3):509-12. PubMed ID: 3196266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenicity of Pasteurella multocida: its variable nature demonstrated by in vivo passages.
    Matsumoto M; Strain JG
    Avian Dis; 1993; 37(3):781-5. PubMed ID: 8257371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro sensitivity of Pasteurella multocida of turkey origin to various chemotherapeutic agents.
    Donahue JM; Olson LD
    Avian Dis; 1972; 16(3):506-11. PubMed ID: 5038650
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of hypovitaminosis A on the pathogenesis of Pasteurella multocida in turkeys.
    Aye PP; Morishita TY; Saif YM; Jonas M
    Avian Dis; 2000; 44(4):818-26. PubMed ID: 11195636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fowl cholera: cross-immunity induced in turkeys with formalin-killed in-vivo-propagated Pasteurella.
    Heddleston KL; Rebers PA
    Avian Dis; 1972; 16(3):578-86. PubMed ID: 5038656
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations on the prevalence of avian Pasteurella multocida serotypes.
    Langpap TJ; Matisheck PH
    Avian Dis; 1970 Aug; 14(3):491-3. PubMed ID: 5456432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.